Trial intelligence / Profile preview

Tadalafil Fumarate for Postoperative Analgesia and Sleep After Robot-Assisted Radical Prostatectomy

ChiCTR2600120990Phase 4Not yet recruiting

Sponsor
Yantai Yuhuangding Hospital
Start
Mar 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of dimethyl fumarate in postoperative pain (2 arms), sponsored by Yantai Yuhuangding Hospital. Primary endpoint: Area under the curve of pain VAS at rest and during activity within 24 hours postoperatively. Planned start Mar 2026; status: not yet recruiting.

02

Drugs

dimethyl fumarate
03

Conditions

postoperative pain

Beyond the preview

Go deeper on ChiCTR2600120990.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2600120990.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call